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Abstract
Background: Hypercholesterolemia is one of the most common risk factors for Coronary Artery Disease (CAD),
which is the leading cause of death worldwide. As Numb is an important regulating factor regarding intestinal
cholesterol absorption and plasma cholesterol level, the aim of the present study is to investigate the relationship
between human Numb gene polymorphism and cholesterol level in Chinese subjects.
Methods: All participants came from the First Affiliated Hospital of Xinjiang Medical University (Male: 1052 and
Female: 596), and four tagging SNPs (rs2108552, rs12435797, rs1019075 and rs17781919) of Numb gene were
genotyped by using TaqMan® assays and analyzed in an ABI 7900HT Fast Real-Time PCR System. Further, general
liner model was applied for assessing the relationship between cholesterol level and genotypes.
Results: By analyzing a dominant model, recessive model and an additive model, we have found that SNP
rs2108552 was associated with total cholesterol (TC) and low density lipoprotein-cholesterol level (LDL-C) (P = 0.000
and P = 0.007; P =0.042 and P =0.009; P = 0.006 and P = 0.030). C allele of SNP rs17781919 had significantly lower
plasma TC level (3.46 ± 0.74 mmol/L vs 4.27 ± 1.1 mmol/L) and LDL-C level (0.98 ± 0.55 mmol/L vs 2.64 ± 0.93 mmol/L)
when compared with T allele. Additionally, SNP rs12435797 was associated with TC level and SNP rs1019075 was
associated with LDL-C level by analyses of a dominant model, recessive model and an additive model (P = 0.000, P =
0.005 and P = 0.004; P = 0.016, P = 0.008 and P = 0.033). Further, the association of rs2108552, rs12435797, rs1019075 and
rs17781919 with aforementioned different kinds of cholesterol levels remained statistically significant after multivariate
adjustment of ethnicity, gender, age, smoking and obesity.
Conclusions: Our results indicated that both rs2108552 and rs17781919 in the Numb gene were associated with total
cholesterol level and density lipoprotein-cholesterol level in Chinese subjects.
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Background
Coronary artery disease (CAD) is the leading cause of
morbidity and mortality in developed countries, and
becoming increasingly prevalent in developing coun-
tries [1–3]. Regarding Coronary artery disease, strong evi-
dence indicates that the risk increasement of CAD [4–7]
is closely related to the rise of plasma cholesterol level.
Studies have demonstrated that a reduction in plasma
total cholesterol (TC) and triglycerides (TG) concentration
independently reduces the risk of CAD [8, 9]. In addition,
convincing data also shows that 1 % decrease in low
density lipoprotein-cholesterol (LDL-C) concentration
reduces the risk of CAD for approximately 1 % [10],
and 1 % increase in high density lipoprotein-cholesterol
(HDL-C) concentration reduces the risk of CAD for
approximately 2 % [11]. Further, other than being de-
termined by environmental factors, the levels of plasma
cholesterol are also influenced by the genetic constitu-
tion of each individual, such as single nucleotide poly-
morphisms (SNPs) [12–15].
Numb is a member of clathrin-associated sorting pro-
teins, and combines with several other endocytic proteins
[16–19]. Pei-Shan Li et al. [20] has revealed that Numb
is an essential regulating factor for maintaining human
cholesterol homeostasis. Numb regulates cholesterol ab-
sorption, and thus plays a crucial role in the development
of atherosclerosis and indicated that pharmacologically
targeting the Numb-NPC1L1 interaction could be a way
to decrease cholesterol absorption and cholesterol level.
Further, Jian Wei et al. [21] has confirmed that there does
exist a remarkable correlation between Numb polymorph-
ism G595D (rs17781919),-a nonsynonymous variant in
the coding region of Numb gene- and low concentration
of LDL-C among humans. They demonstrated that
rs17781919 influences Numb activity of driving NPC1L1
internalization and decreases cholesterol absorption and
leading to low plasma cholesterol level.
Unfortunately, the relationship between human Numb
gene and lipid profile has not been thoroughly studied yet.
Therefore, the aim of the present study is to reveal the re-
lationship between some genetic variants of human Numb
gene and lipid profile among Chinese population in
Xinjiang, China, hoping to provide additional information




Altogether, 1742 (Male: n = 1117; Female: n = 625) were
randomly selected from the First Affiliated Hospital of
Xinjiang Medical University that belong to a time period
ranges from January 2007 to December 2013 for DNA
analysis. The inclusion and exclusion criteria was such
as: The analysis presented in this study was based on
1648 subjects (Male: n = 1052; Female: n = 596) who had
passed the eligibility criteria and had complete data on
Numb genotype. Further, all of these subjects live in
Xinjiang Uighur Autonomous Region of China, and
none of them suffers from impaired malignancy, con-
nective tissue disease, renal function, valvular disease or
chronic inflammatory disease. Moreover, subjects also
are free from thyroid disease, or any history of taking
lipid-lowering drugs. In addition we excluded 92 hyper-
cholesterolemia (fasting plasma TC ≥ 6.26 mmol/L or
fasting plasma LDL-C ≥ 4.14 mmol/L [22]) patients
during the analysis.
Lifestyle measurements and blood biochemical analysis
Height and body weight were measured as described pre-
viously [23], and body mass index (BMI) was calculated by
dividing the weight in kilogram to the square of height in
meter. The status of smoking was described as smokers
(including current and ex-smokers) or non-smokers. Fur-
ther, WHO Asia-Pacific Area criterion- BMI ≥25 kg/m2
was used to define obesity as described in detail previously
[23]. Finally, blood urea nitrogen (BUN), creatinine (Cr),
uric acid, glucose, total cholesterol (TC), triglyceride (TG),
low density lipoprotein-cholesterol (LDL-C), and high
density lipoprotein-cholesterol (HDL-C) were measured
by using chemical analysis equipment (Dimension AR/
AVL Clinical Chemistry System, Newark, NJ) in Clinical
Laboratory Department of the First Affiliated Hospital of
Xinjiang Medical University [24, 25].
Ethical approval of the study protocol
All participants have given their written informed consent
and explicit permission for DNA analysis as well as for the
collection of relevant clinical data. This study was ap-
proved by the Ethics Committee of the First Affiliated
Hospital of Xinjiang Medical University (Urumqi, China)
and was conducted by strictly following the requirements
of the Declaration of Helsinki.
SNP selection
The human Numb gene includes phosphotyrosine-
binding (PTB) domain and proline-rich region (PRR)
domain [26–29] and has four transcript variants that
encode four different isoforms, which are p72
(PTBLPRRL), p71 (PTBSPRRL), p65 (PTBSPRRS), and
p66 (PTBLPRRS). Isoform p72 of the Numb gene,
which has the longest length among the four isoforms,
consists of 651 amino acids. It is located on chromo-
some 14q24.3 and contains 13 exons which are further
separated by 12 introns. There are 3781 different kinds
of SNPs of human Numb gene as listed in the National
Center for Biotechnology Information SNP database
(http://www.ncbi.nlm.nih.gov/SNP). For the current
study, we have screened the HapMap phase I & II
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database and Haploview 4.0 software for the tag SNPs of
Numb gene and selected three SNPs (rs2108552,
rs12435797, and rs1019075). Meanwhile, we also included
rs17781919 from the Numb gene which was associated
with LDL-C [21]. SNPs with relatively high minor allele
frequencies (MAFs) have been shown to be useful as
genetic markers in genetic association studies [30] and
all four tag SNPs that selected for the present study
had a MAF of ≥0.1. In addition, linkage disequilibrium
(LD) is the non-random association of alleles at differ-
ent loci, and we described LD patterns with r2 ≥ 0.8 as a
cut-off for the tag SNPs [31].
Genotyping
Blood samples were taken from all participants by
using anticoagulant ethylene diaminetetraacetic acid
(EDTA) tube, and standard phenol-chloroform method
was used to extract genomic DNA from peripheral leu-
kocytes [32]. Further, genotyping was undertaken by
using TaqMan® assays from Applied Biosystems follow-
ing the manufacturer’s suggestions and analyzed in an
ABI 7900HT Fast Real-Time PCR System [33], and the
detailed information of the TaqMan SNP Genotyping
method was as follows. Allele-specific fluorogenic probes
were hybridised to the template in the first step of the 5′
nuclease assay. Then, during the polymerase chain reac-
tion (PCR), the 5′ nuclease activity of the Taq polymerase
made it possible for discrimination. In addition, the probes
include a 3′ minor groove binding group that hybridises
to single-stranded targets and has greater sequence speci-
ficity when compared to the original DNA probes. This re-
duces nonspecific probe hybridization which leads to low
background fluorescence for the 5′ nuclease PCR assay
(TaqMan; Applied Biosystems). Cleavage results in the in-
creased emission of a reporter dye. Two unlabeled PCR
primers and two allele-specific probes were required for
each 5′ nuclease assay. At the 5′ end, each probe is la-
beled with two reporter dyes. In the present study, VIC
and FAM were used as the reporter dyes. The probes and
primers used in TaqMan®SNP Genotyping Assays (ABI)
were selected according to the information on ABI website
(http://www.appliedbiosystems.com/absite/us/en/home.html).
Finally, PCR amplification was performed by using
0.05 μL probes, 3 μL of TaqMan Universal Master Mix,
1 μL DNA, and 1.95 ddH2O in a 6 μL final reaction vol-
ume. In addition, thermal cycling conditions for PCR
amplification were 95 °C for 10 min, 45 cycles of 95 °C for
10 s and 60 °C for 1 min. Moreover, thermal cycling was
undertaken by using Applied Biosystems7900HT Standard
Real-Time PCR System, and all 96 well plates were read
according to Sequence Detection Systems (SDS) automa-
tion controller software v2.3 (ABI).
Quality control
There was at least one negative and one positive control
per 96-well DNA plate in our assays. We have found
100 % concordance between the genotyped duplicate
samples (10 %) for each of the SNPs by testing the ac-
curacy of the genotyping. The rate of genotyping success
for each SNP was 98 %.
Statistical analysis
All statistical analyses were performed via using
SPSS16.0 software for Windows (SPSS Institute, Chicago,
IL, USA). Further, Hardy-Weinberg equilibrium was
assessed by χ2 analysis for all subjects, and all of the
Table 1 Clinical and metabolic characteristics of subjects
Risk factor No. (%) or mean (SD)
Total Male Female P value
Age (years) 56.33 (9.83) 55.28 (10.09) 58.22 (9.03) 0.000*
BUN (mmol/L) 5.07 (1.82) 5.01 (1.85) 5.20 (1.78) 0.036*
Cr (mmol/L) 71.04 (17.18) 72.26 (17.29) 68.98 (16.79) 0.000*
Uric acid (mmol/L) 313.70 (89.96) 316.76 (87.43) 308.51 (93.79) 0.078
Glucose (mmol/L) 5.68 (2.43) 5.74 (2.41) 5.58 (2.39) 0.189
Total cholesterol (mmol/L) 4.27 (1.11) 4.33 (1.18) 4.23 (1.07) 0.083
Triglyceride (mmol/L) 1.97 (1.49) 2.01 (1.81) 1.94 (1.28) 0.401
LDL-C (mmol/L) 2.65 (0.91) 2.69 (0.99) 2.62 (0.86) 0.188
HDL-C (mmol/L) 1.05 (0.55) 1.04 (0.55) 1.06 (0.54) 0.378
Obesity (%) 1026 (63.1) 641 (61.6) 385 (66.0) 0.077
Smoking (%) 1031 (62.4) 737 (69.9) 293 (49.2) 0.000*
Continuous variables are expressed as mean ± SD. Categorical variables are expressed as percentages
The P value of the continuous variables was calculated by the independent samples t test. The P value of the categorical variables was calculated by x2 test
BUN blood urea nitrogen, Cr Creatinine, LDL-C low density lipoprotein-cholesterol, HDL-C high density lipoprotein-cholesterol
*P < 0.05
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Table 2 Distribution of SNPs of Numb gene for study population
Varients Total N (%) Male N (%) Female N (%) P value
rs2108552 (SNP1)
Genotype C/C 281 (17.0) 174 (16.5) 107 (18.0) 0.732
G/G 568 (34.4) 367 (34.8) 201 (33.7)
C/G 799 (48.6) 511 (48.7) 288 (48.3)
Dominant model CC 281 (17.0) 174 (16.5) 107 (18.0) 0.464
CG + GG 1367 (83.0) 878 (83.5) 489 (82.0)
Recessive model GG 568 (34.4) 367 (34.8) 201 (33.7) 0.634
CG + CC 1080 (65.6) 685 (65.2) 395 (66.3)
Additive model CG 799 (48.6) 511 (48.7) 288 (48.3) 0.922
CC + GG 849 (51.4) 541 (51.3) 308 (51.7)
Allele C 1361 (41.3) 859 (40.8) 502 (42.1) 0.471
G 1935 (58.7) 1245 (59.2) 690 (57.9)
rs12435797 (SNP2)
Genotype T/T 532 (32.3) 323 (30.7) 209 (35.1) 0.111
G/G 348 (21.1) 235 (22.3) 113 (19.0)
G/T 768 (46.6) 495 (47.0) 273 (45.9)
Dominant model TT 532 (32.3) 323 (30.7) 209 (35.1) 0.063
GT + GG 1116 (67.7) 730 (69.3) 386 (64.9)
Recessive model GG 348 (21.1) 235 (22.3) 113 (19.0) 0.112
GT + TT 1300 (78.9) 818 (77.7) 482 (81.0)
Additive model GT 768 (46.6) 495 (47.0) 273 (45.9) 0.660
TT + GG 880 (53.4) 558 (53.0) 322 (54.1)
Allele T 1832 (55.6) 1141 (54.2) 691 (58.1) 0.031*
G 1464 (44.4) 965 (45.8) 499 (41.9)
rs1019075 (SNP3)
Genotype C/C 176 (10.7) 115 (10.9) 61 (10.2) 0.846
T/T 848 (51.5) 536 (51.0) 312 (52.3)
C/T 624 (37.9) 401 (38.1) 223 (37.4)
Dominant model CC 176 (10.7) 115 (10.9) 61 (10.2) 0.660
CT + TT 1472 (89.3) 937 (89.1) 535 (89.8)
Recessive model TT 848 (51.5) 536 (51.0) 312 (52.3) 0.585
CT + CC 800 (48.5) 516 (49.0) 284 (47.7)
Additive model CT 624 (37.9) 401 (38.1) 223 (37.4) 0.778
CC + TT 1024 (62.1) 651 (61.9) 373 (62.6)
Allele C 976 (29.6) 631 (30.0) 345 (28.9) 0.527
T 2320 (70.4) 1473 (70.0) 847 (71.1)
rs17781919 (SNP4)
Genotype C/C 1621 (98.4) 1034 (98.0) 587 (99.0) 0.133
C/T 27 (1.6) 21 (2.0) 6 (1.0)
Allele C 3269 (99.2) 2089 (99.0) 1180 (99.5) 0.135
T 27 (0.8) 21 (1.0) 6 (0.5)
The P value of genotype was calculated by Fisher’s exact test
*P <0.05
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continuous variables were expressed via mean ± standard
deviation. Furthermore, differences among the frequency
of obesity, smoking and Numb genotypes were analyzed
through χ2 test or Fisher’s exact test. Finally, after adjust-
ing confounding variables, general linear model analysis
was undertaken to test the association between Numb
genotypes and lipid profile. In addition, P < 0.05was con-
sidered as a criterion for statistical significance.
Results
Characteristics of the subjects
The study cohort includes 1648 subjects (1052 male, 596
female), and all of them were selected from Out-patient
and In-patient department of the First Affiliated Hospital
of Xinjiang Medical University that belong to a time
period ranges from January 2007 to December 2013.
Results of outcome measures
1. The clinical and metabolic characteristics of the
study population are shown separately for male and
female in Table 1. In females, plasma concentration
of BUN is higher than to males (P = 0.036). Further,
in males, plasma concentration of creatinine,
prevalence of smoking is higher than females
(all P = 0.000). In addition, there were no significant
differences between males and females on plasma
concentration of uric acid, glucose, TC,TG, LDL-C
and HDL-C or prevalence of obesity (All P > 0.05).
2. The distribution of genotypes of SNPs (all genotyped
frequencies of SNPs were in Hardy-Weinberg
equilibrium, data not shown) of Numb gene is
shown in Table 2. We observed that there were no
significant differences between males and females for
4 SNPs (All P > 0.05; genotypes, dominant, recessive
and additive models). In addition, for the alleles, we
found that there was significant difference between
males and females for SNP rs12435797 (P = 0.031).
Further, we found that there was no significant
difference between males and females for rs2108552,
rs1019075, and rs17781919 (All P > 0.05).
3. Numb genotypes and lipid profile
i. We found that the rs2108552 was significantly
associated with plasma TC and LDL-C level in a
dominant model, additive model, or recessive
model before (All P < 0.05) and after multivariate
adjustment of ethnicity, gender, age, smoking and
obesity (All P < 0.05; Table 3). Further, the
rs2108552 was significantly associated with
plasma HDL-C level in a dominant model before
(P = 0.000) and after multivariate adjustment
(P = 0.012; Table 3).
ii. By analyzing a dominant model, additive model,
or recessive model, we found that the rs12435797
was significantly associated with plasma TC level
before (All P < 0.05) and after multivariate
adjustment of ethnicity, gender, age, smoking and
obesity. (All P < 0.05; Table 4). In addition, we
Table 3 Associations between rs2108552 and lipid parameters
Mean ± SD Model 1 Model 2
Homozygous
for wild allele (C)
Heterozygous Homozygous
for rare allele (G)
P (Dom) P (Rec) P (Add) P (Dom) P (Rec) P (Add)
TC (mmol/L) 4.35 ± 1.24 4.34 ± 1.02 3.89 ± 1.01 0.000 0.042 0.006 0.000 0.007 0.015
LDL-C (mmol/L) 2.64 ± 0.96 2.70 ± 0.90 2.51 ± 0.83 0.007 0.009 0.030 0.000 0.004 0.011
HDL-C (mmol/L) 1.02 ± 0.56 1.02 ± 0.48 1.15 ± 0.67 0.000 0.213 0.120 0.012 0.913 0.083
TG (mmol/L) 1.99 ± 1.62 1.97 ± 1.41 1.91 ± 1.47 0.478 0.676 0.889 0.386 0.503 0.954
TC total cholesterol, LDL-C low density lipoprotein-cholesterol, HDL-C high density lipoprotein-cholesterol, TG triglycerides, Dom dominant model, Rec recessive model,
Add additive model
Model 1: Unadjusted model; Model 2: Analysis of covariance adjusted for ethnicity, gender, age, smoking and obesity
Table 4 Associations between rs12435797 and lipid parameters
Mean ± SD Model 1 Model 2
Homozygous
for wild allele (T)
Heterozygous Homozygous
for rare allele (G)
P (Dom) P (Rec) P (Add) P (Dom) P (Rec) P (Add)
TC (mmol/L) 4.30 ± 1.28 4.36 ± 1.09 4.13 ± 1.02 0.000 0.005 0.004 0.007 0.006 0.016
LDL-C (mmol/L) 2.60 ± 0.96 2.70 ± 0.96 2.60 ± 0.80 0.171 0.279 0.030 0.808 0.545 0.527
HDL-C (mmol/L) 1.03 ± 0.66 1.01 ± 0.38 1.11 ± 0.67 0.001 0.494 0.010 0.874 0.791 0.833
TG (mmol/L) 1.94 ± 1.35 2.02 ± 1.60 1.93 ± 1.43 0.506 0.758 0.381 0.651 0.942 0.545
TC total cholesterol, LDL-C low density lipoprotein-cholesterol, HDL-C high density lipoprotein-cholesterol, TG triglycerides, Dom dominant model, Rec recessive model,
Add additive model
Model 1: Unadjusted model; Model 2: Analysis of covariance adjusted for ethnicity, gender, age, smoking and obesity
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also found that rs12435797 was associated with
HDL-C level in a dominant and an additive
model (P = 0.001, P = 0.010). However, the
difference did not remain statistically significant
after multivariate adjustment.
iii. We observed that the rs1019075 was significantly
associated with plasma LDL-C and HDL-C level
by analyses of a dominant model, additive model,
or recessive model before (All P < 0.05) and after
multivariate adjustment of ethnicity, gender, age,
smoking and obesity (All P < 0.05; Table 5).
iv. We found that rs17781919 was significantly
associated with TC, LDL-C and HDL-C level
(All P ≤ 0.000) and the difference remained
statistically significant after (All P ≤ 0.001;
(Table 6) multivariate adjustment of ethnicity,
gender, age, smoking and obesity.
v. In addition, there exist no significant difference
between different genotypes and the alleles of four




In this study, we have genotyped four kinds of SNP of
Numb gene, and found that variation in Numb gene as-
sociates with cholesterol levels among Chinese subjects.
This is the first endeavor to study the common allelic
variant in Numb gene and its association with four
types of lipid parameters.
Hypercholesterolemia has been observed to be the cause
of multiple physiologic outcomes, such as coronary artery
disease, diabetes, and obesity [34–36]. Previous study indi-
cates that Numb gene may provide a therapeutic target for
hypercholesterolemia [20]. Meanwhile, Numb genetic
variant was directly responsible for the decreased LDL-C
concentration [21]. However, few researches have been
conducted regarding the relationship between polymorph-
ism of Numb gene and lipid profile.
Our study shows that rs2108552 was significantly as-
sociated with plasma TC and LDL-C level by analyses
of a dominant model, additive model, or recessive
model. Such association was remained significant after
multivariate adjustment. Further, individuals with the C
allele of rs2108552 had significantly higher plasma TG
and LDL-C level when compared with G allele. To our
knowledge, a high level of LDL-C and TC concentra-
tion in plasma increase the risk of atherosclerotic car-
diovascular disease. In previous study, we have found
that rs2108552 of Numb gene was associated with
CAD among Chinese subjects, and thus assumed CC
genotype might be a risk genetic marker for CAD. To-
gether, these results might provide convincing evidence
for assuming people who carry C allele may have higher
probabilities of suffering from atherosclerotic cardio-
vascular disease (CVD) than people who carry G allele
of rs2108552 of Numb gene.
We also observed that C allele of SNP rs17781919 had
significantly lower plasma TC level, LDL-C level and high
HDL-C level when compared with T allele and further
proved that this variation was associated with low level of
LDL-C among large population. Moreover, these results
also indicate that people who carry C allele reduces the
risk of atherosclerotic cardiovascular disease (CVD) when
compared to the people who carry T allele.
Similarly, we observed that the rs12435797 was signifi-
cantly associated with plasma TC level, and rs1019075 was
significantly associated with LDL-C and HDL-C level. Fur-
ther, individuals with GG genotype of rs12435797
Table 5 Associations between rs1019075 and lipid parameters
Mean ± SD Model 1 Model 2
Homozygous
for wild allele (C)
Heterozygous Homozygous
for rare allele (T)
P (Dom) P (Rec) P (Add) P (Dom) P (Rec) P (Add)
TC (mmol/L) 4.25 ± 1.02 4.30 ± 1.23 4.22 ± 1.10 0.568 0.553 0.331 0.324 0.120 0.029
LDL-C (mmol/L) 2.68 ± 0.90 2.63 ± 0.91 2.57 ± 0.97 0.016 0.008 0.033 0.029 0.007 0.043
HDL-C (mmol/L) 1.02 ± 0.77 1.01 ± 0.46 1.08 ± 0.55 0.022 0.322 0.047 0.031 0.469 0.062
TG (mmol/L) 1.97 ± 1.45 1.95 ± 1.55 2.01 ± 1.47 0.662 0.936 0.719 0.367 0.707 0.353
TC total cholesterol, LDL-C low density lipoprotein-cholesterol, HDL-C high density lipoprotein-cholesterol, TG triglycerides, Dom dominant model, Rec recessive model,
Add additive model
Model 1: Unadjusted model; Model 2: Analysis of covariance adjusted for ethnicity, gender, age, smoking and obesity
Table 6 Associations between rs17781919 and lipid parameters
Mean ± SD Model 1 Model 2
Wild allele (T) Rare allele (C)
TG (mmol/L) 1.97 ± 1.50 1.66 ± 0.93 0.315 0.330
TC (mmol/L) 4.27 ± 1.11 3.46 ± 0.74 0.000 0.001
LDL-C (mmol/L) 2.64 ± 0.93 0.98 ± 0.55 0.000 0.000
HDL-C (mmol/L) 1.05 ± 0.49 1.92 ± 0.49 0.000 0.000
TC total cholesterol, LDL-C low density lipoprotein-cholesterol, HDL-C high
density lipoprotein-cholesterol, TG triglycerides
Model 1: Unadjusted model; Model 2: Analysis of covariance adjusted for
ethnicity, gender, age, smoking and obesity
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demonstrate low TC level compared with individuals with
TT genotype, and individuals with TT genotype of
rs1019075 also demonstrate low LDL-C level and high
HDL-C level compared with individuals with CC geno-
type. Such association was also remained significant
after multivariate adjustment. Therefore, we assumed
that people who carry G allele of rs12435797 and T al-
lele of rs1019075 may have lower probabilities of suf-
fering from atherosclerotic cardiovascular disease
(CVD) when compared to the people who carry T allele
of rs12435797 and C of rs1019075 allele.
In addition, we have not observed a remarkable differ-
ence between TG level and three kinds of SNPs of
Numb gene. This might indicate Numb gene does not
have as strong correlation with TG concentration as it
does with cholesterol concentration. Nevertheless, the
relationship between TG concentration and Numb gene
needs further study.
Limitations and shortcomings
First, the source of subjects was limited to the First
Affiliate Hospital of Xinjiang Medical University, and
these subjects may possess some risk factors of cardio-
vascular disease and different kinds of lifestyles that both
might positively influence lipid profile. Second, a longi-
tudinal epidemiological study, over a reasonably long
time span, is required to obtain evidence with higher
quality and reliability.
Conclusion
Our results indicate Numb gene rs2108552 and
rs17781919 polymorphisms closely associate with choles-
terol level, and this kind of association could be a crucial
genetic marker and determinant in clinical research.
Nevertheless, our study requires further epidemiological
survey by resorting to large numbers of samples.
Abbreviations
CAD: Coronary artery disease; LDL-C: Low density lipoprotein-cholesterol;
HDL-C: High density lipoprotein-cholesterol; TC: Total cholesterol;
TG: Triglycerides; SNPs: Single nucleotide polymorphisms; BMI: Body mass
index; BUN: Blood urea nitrogen; Cr: Creatinine; PTB:
Phosphotyrosine-binding domain; PRR: Proline-rich region domain;
MAF: Minor allele frequency; DNA: Deoxyribonucleic acid;
EDTA: Ethylenediaminetetraacetic acid; PCR: Polymerase chain reaction;
SDS: Sequence detection systems; CVD: Cardiovascular disease.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MA, ZYF and YTM conceived and designed the study. MA, ZYF, QZ, DA and MA
performed the study. YX, XML, XX, FL and BDC analyzed the data. MA, ZYF, YTM
and YNY wrote the paper. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by grants from Science and Technology Program
of Xinjiang Uighur Autonomous Region (2013911111).
Author details
1Department of Cardiology, the First Affiliated Hospital of Xinjiang Medical
University, Urumqi 830001, People’s Republic of China. 2Xinjiang Key
Laboratory of Cardiovascular Disease Research, Urumqi 830001, People’s
Republic of China. 3The First Affiliated Hospital of Xinjiang Medical University,
Urumqi 830001, People’s Republic of China. 4Present address: Department of
Cardiology, the First Affiliated Hospital of Xinjiang Medical University, Li Yu
Shan South Road 137, Urumqi 830001, People’s Republic of China. 5Present
address: Xinjiang Key Laboratory of Cardiovascular Disease Research, Li Yu
Shan South Road 137, Urumqi 830001, People’s Republic of China.
Received: 9 June 2015 Accepted: 28 July 2015
References
1. Kreisberg RA, Oberman A. Clinical review 141: lipids and atherosclerosis:
lessons learned from randomized controlled trials of lipid lowering and
other relevant studies. In J Clin Endocrinol Metab. 2002;87(2):423–37.
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al.
Heart disease and stroke statistics-2011 update: a report from the American
Heart Association. Circulation. 2011;123:e18–209.
3. Writing Group M, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S,
et al. Heart disease and stroke statistics–2010 update: a report from the
American Heart Association. Circulation. 2010;121:e46–215.
4. Mackay J, Mensah GA. The Atlas of Heart Disease and Stroke (World Health
Organization) Geneva; 2004.
5. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density
lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic
review and meta-analysis. Br Med J. 2003;326(7404):1423.
6. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H,
et al. Estimation of contribution of changes in classic risk factors to trends
in coronary-event rates across the WHO MONICA Project populations.
Lancet. 2000;355:675–87.
7. Clarke R, Emberson JR, Parish S, Palmer A, Shipley M, Linksted P, et al.
Cholesterol fractions and apolipoproteins as risk factors for heart disease
mortality in older men. Arch Intern Med. 2007;167:1373–8.
8. Bhagavan NV. Medical Biochemistry. 4th ed. San Diego: Harcourt/Academic
Press; 2002. p. 1016.
9. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Non-fasting
triglycerides and risk of myocardial infarction, ischemic heart disease, and
death in men and women. J Am Med Assoc. 2007;298:299–308.
10. Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB,
et al. Implications of recent clinical trials for the National Cholesterol
Education Program Adult Treatment Panel III guidelines. Circulation.
2004;110:227–39.
11. Gotto Jr AM, Brinton EA. Assessing low levels of high-density lipoprotein
cholesterol as a risk factor in coronary heart disease: a working group report
and update. J Am Coll Cardiol. 2004;43:717–24.
12. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, et
al. Loci influencing lipid levels and coronary heart disease risk in 16
European population cohorts. Nat Genet. 2009;41:47–55.
13. Chasman DI, Paré G, Zee RY, Parker AN, Cook NR, Buring JE, et al. Genetic
loci associated with plasma concentration of low-density lipoprotein
cholesterol, high-density lipoprotein cholesterol, triglycerides,
apolipoprotein A1, and apolipoprotein B among 6382 white women in
genome-wide analysis with replication. Circ Cardiovasc Genet. 2008;1:21–30.
14. Edmondson AC, Braund PS, Stylianou IM, Khera AV, Nelson CP, Wolfe ML, et
al. Dense genotyping of candidate gene loci identifies variants associated
with high-density lipoprotein cholesterol. Circ Cardiovasc Genet.
2011;4:145–55.
15. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, et al.
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat
Genet. 2009;41:56–65.
16. Roncarati R, Sestan N, Scheinfeld MH, Berechid BE, Lopez PA, Meucci O, et
al. The gamma-secretase-generated intracellular domain of beta-amyloid
precursor protein binds Numb and inhibits Notch signaling. Proc Natl Acad
Sci U S A. 2002;99:7102–7.
17. Dho SE, Jacob S, Wolting CD, French MB, Rohrschneider LR, McGlade CJ.
The mammalian numb phosphotyrosine-binding domain. Characterization
of binding specificity and identification of a novel PDZ domain-containing
numb binding protein, LNX. J Biol Chem. 1998;273:9179–87.
Abudoukelimu et al. Diagnostic Pathology  (2015) 10:141 Page 7 of 8
18. Nishimura T, Kaibuchi K. Numb controls integrin endocytosis for directional
cell migration with aPKC and PAR-3. Dev Cell. 2007;13:15–28.
19. Tong X, Zitserman D, Serebriiskii I, Andrake M, Dunbrack R, Roegiers F.
Numb independently antagonizes Sanpodo membrane targeting and
Notch signaling in Drosophila sensory organ precursor cells. Mol Biol Cell.
2010;21:802–10.
20. Li PS, Fu ZY, Zhang YY, Zhang JH, Xu CQ, Ma YT, et al. The clathrin adaptor
Numb regulates intestinal cholesterol absorption through dynamic
interaction with NPC1L1. Nat Med. 2014;20:80–6.
21. Wei J, Fu ZY, Li PS, Miao HH, Li BL, Ma YT, et al. The clathrin adaptor
proteins ARH, Dab2, and numb play distinct roles in Niemann-Pick C1-Like 1
versus low density lipoprotein receptor-mediated cholesterol uptake. J Biol
Chem. 2014;289:33689–700.
22. SoRelle R. ATP III, calls for more intensive low-density lipoprotein lowering
in target groups. Circulation. 2002;106:e9068–8.
23. Patel S, Flyvbjerg A. Koza’kova’ M, Frystyk J, Ibrahim IM, Petrie JR, et al.
Variation in the ADIPOQ gene promoter is associated with carotid intima
media thickness independent of plasma adiponectin levels in healthy
subjects. Eur Heart J. 2008;29:386–93.
24. Zheng YY, Xie X, Ma YT, Yang YN, Fu ZY, Li XM, et al. Relationship between
a novel polymorphism of the C5L2 gene and coronary artery disease.
PLoS One. 2011;6:e20984.
25. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, Chen BD, et al. Association of
polymorphisms of PTGS2 and CYP8A1 with myocardial infarction.
Clin Chem Lab Med. 2009;47:347–52.
26. Verdi JM, Bashirullah A, Goldhawk DE, Kubu CJ, Jamali M, Meakin SO, et al.
Distinct human NUMB isoforms regulate differentiation vs. proliferation in
the neuronal lineage. Proc Natl Acad Sci U S A. 1999;96:10472–6.
27. Zwahlen C, Li SC, Kay LE, Pawson T, Forman-Kay JD. Multiple modes of
peptide recognition by the PTB domain of the cell fate determinant Numb.
EMBO J. 2000;19:1505–15.
28. Li SC, Zwahlen C, Vincent SJ, McGlade CJ, Kay LE, Pawson T, et al. Structure
of a Numb PTB domain-peptide complex suggests a basis for diverse
binding specificity. Nat Struct Biol. 1998;5:1075–83.
29. Li SC, Songyang Z, Vincent SJ, Zwahlen C, Wiley S, Cantley L, et al.
High-affinity binding of the Drosophila Numb phosphotyrosine-binding
domain to peptides containing a Gly-Pro-(p)Tyr motif. Proc Natl Acad Sci U S A.
1997;94:7204–9.
30. Naganuma T, Nakayama T, Sato N, Fu Z, Yamaguchi M, Soma M, et al.
Haplotype-based case-control study between human apurinic/apyrimidinic
endonuclease 1/redox effector factor-1 gene and cerebral infarction.
Clin Biochem. 2009;42:1493–9.
31. Li X, Ma YT, Xie X, Yang YN, Ma X, Zheng YY, et al. Association of Egr3
genetic polymorphisms and coronary artery disease in the Uygur and Han
of China. Lipids Health Dis. 2014;13:84.
32. Nakayama T, Soma M, Rahmutula D, Ozawa Y, Kanmatsuse K. Isolation of
the 5′-flanking region of genes by thermal asymmetric interlaced
polymerase chain reaction. Med Sci Monit. 2001;7:345–9.
33. Sano M, Kuroi N, Nakayama T, Sato N, Izumi Y, Soma M, et al. The
association study of calcitonin-receptor-like receptor gene in essential
hypertension. Am J Hypertens. 2005;18:403–8.
34. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin
Invest. 2006;116:1793–801.
35. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking
obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol.
2008;9:367–77.
36. Blüher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol
Diabetes. 2009;117:241–50.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Abudoukelimu et al. Diagnostic Pathology  (2015) 10:141 Page 8 of 8
